Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study

Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study

BackgroundReports on Lenvatinib-based therapies show promising treatment outcomes for patients with unresectable hepatocellular carcinoma (uHCC). However, the effect and safety of Lenvatinib-based therapies still need to be further studies.MethodsThis was a retrospective, single-center study on the...

Full description

Bibliographic Details
Main Authors: Jian Huang, Zhen-Guang Wang, Qi-Fei Tao, Yun Yang, Sheng-Xian Yuan, Fang-Ming Gu, Hui Liu, Ze-Ya Pan, Bei-Ge Jiang, Wan Yee Lau, Wei-Ping Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Immunology
Subjects:
hepatocellular carcinoma
Lenvatinib
combination therapy
PD-1
tumor-downstaging
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1198562/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1198562/full

Similar Items